Shineway Pharmaceutical (2877.HK) recorded 29.4% revenue growth for October 2020

HONG KONG, Nov 30, 2020 – (ACN Newswire) – Shineway Pharmaceutical (stock code: 2877.HK) recorded 29.4% revenue growth for October 2020 in comparison with the same period last year, as sales of injection products, soft capsule products, granule products, TCM formula granules, and other dosage forms went up 38.9%, 17.4%, 38.1%, 7.9% and 54.0% respectively.

Copyright 2020 ACN Newswire. All rights reserved.

Next Post

Mitsubishi Heavy Industries Invests in Monolith Materials

Sen Nov 30 , 2020
TOKYO, Nov 30, 2020 – (JCN Newswire) – Mitsubishi Heavy Industries, Ltd. (MHI) has completed a capital investment in Monolith Materials, Inc. (Monolith), a U.S. company with innovative technology enabling the production of hydrogen and carbon black from methane, which is abundant in natural gas, by the process of methane […]